Regeneron (United States)

Recent papers from Regeneron (United States)

1. Bacterial major vault protein homologs form divergent vault structures2026
2. A Liver-Targeted CIDEB siRNA in Adults with MASLDNew England Journal of Medicine · 2026
3. Simulation of low-density lipoprotein cholesterol goal attainment with treatment intensification in a population with homozygous familial hypercholesterolemiaAtherosclerosis Plus · 2026
4. Evinacumab for children and adolescents with homozygous familial hypercholesterolemia: a plain language summaryExpert Review of Cardiovascular Therapy · 2026
5. High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugationGene Therapy · 2026
6. Efficacy of Dupilumab in Patients From China With Persistent Type 2 Asthma With and Without an Allergic PhenotypeClinical & Experimental Allergy · 2026
7. Pharmacokinetics, efficacy and safety of dupilumab administered with prefilled pen devices in patients aged <12 years with atopic dermatitisBritish Journal of Clinical Pharmacology · 2026
8. Quantitative imaging of native tissue architecture combined with deep multi-omics reveals the spatial biology of kidney aging2026
9. Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trialTrials · 2026
10. Alzheimer’s disease genetics converges on microglial and neuronal dysregulationNature · 2026
11. Would Artificial Intelligence Make ‘Good’ Decisions About Thyroid Nodule Biopsies?The Journal of Clinical Endocrinology & Metabolism · 2026
12. From Enrichment to Insight: Leveraging Preparative cIEF Enrichments and Characterization to Support Data‐Driven Integration Practices for cIEF‐based AnalyticsElectrophoresis · 2026
13. Phase II Study of Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous Cell Carcinoma: Final AnalysisJournal of Clinical Oncology · 2026
14. CAR ‐ HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B‐cell non‐Hodgkin lymphomaBritish Journal of Haematology · 2026
15. Understanding Holistic Patient-Relevant Measurement in Amyotrophic Lateral Sclerosis: A Mixed-Methods Content Validity and Exploratory Rasch Analysis of Selected Clinical Outcome AssessmentsNeurology and Therapy · 2026
16. Ultrasensitive Quantification of Poloxamer 188 in Adeno-Associated Virus Products by All-Ion Fragmentation MS/MSAnalytical Chemistry · 2026
17. Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet · 2026
18. Single-Blind, Multicenter Evaluation of Diagnostic and Clinical Decision-Making Performance of Generative-AI Large Language Models in Common and Rare Lipid DisordersAtherosclerosis · 2026
19. Adverse Events in the Evinacumab Clinical Development Programme in Homozygous Familial Hypercholesterolaemia (Hofh): Focus on Immunogenicity, Liver Function, and PregnancyAtherosclerosis · 2026
20. Effect of Evinacumab on Lp(a) Levels in Adults and Adolescents With Homozygous Familial Hypercholesterolaemia (Hofh): Insights From the Elipse-Open Label Extension StudyAtherosclerosis · 2026